Greenhouse Solutions Inc. Announces Addition of Key Members to the Company's Advisory Board - Seite 2

"The complementary alternative medicine field is fast growing perhaps due to the long list of side effects associated the modern allopathic medicines," stated Dr. M.S. Reddy. "Any natural botanical product which has therapeutic effects is worth researching. Since the Probiotics are well accepted all over the world, it is only natural to take advantage of synergy between the botanical products of Greenhouse Solutions and the health promoting Probiotics." Dr. M.S Reddy continued, "This perhaps may be the wave of the future to discover the new drugs, with least side effects, to reduce the incurable diseases through research and development. This is the beginning of new era to come up with medicaments which may alleviate the pain and suffering due to severe but chronic metabolic diseases, which have been plaguing the humans and animals (including household pets), for a long, long time," Dr. M.S. Reddy concluded.

Mr. Rost holds the degree of Juris Doctor with Honors from the University of Texas and is a senior partner with the firm of Lewis & Rost, intellectual property lawyers with offices in Denver and northern Colorado. He specializes in practice before the U.S. Patent and Trademark Office and obtains patents worldwide through his network of leading attorneys in every major country around the globe. In addition, he has taught business law and served as an expert witness in numerous federal and state courts in both patent and trademark causes. Areas of patent expertise include environmental remediation, chemistry, pharmaceuticals, biotechnology, therapeutics, probiotics, and nutraceuticals. Some of the areas where he has secured protection for leading edge technologies include cleaning geothermal steam feeding power plants while increasing turbine output, localized cleaning of aquaculture waters by application of specialized biochemical feeds in proximity to the stock in a body of water, treating water supplies with easily renewed agents to remove heavy metals, synergistic combinations of pharmaceuticals and probiotics, and treating divided food products to impart superior handling characteristics. 

"I'm very happy to be a part of a company developing the next generation of therapeutic agents from a largely overlooked resource," stated Kyle W. Rost, "The benefits will be a new source of treatment for people with conditions that have long begged for greater attention and more effective care. The company will pursue a strong, proprietary portfolio of these technologies in which I will aide in protecting every step of the way," Mr.Rost concluded.